An interventional study of Life skills, training, education and work/volunteer opportunities and Usual Care in Nicotine Dependence and Substance Use Disorders, sponsored by Ottawa Hospital Research Institute. Enrolling by invitation at 1 site in Canada. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-24.
Sponsored by Ottawa Hospital Research Institute · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 43 studies in Tobacco Use Disorder with a site in Canada — 10 open to participants now, 10 under way, 1 of them phase 3. Tobacco Use Disorder · Canada.
Among the 43 studies in Tobacco Use Disorder with a site in Canada, this one is the 9th largest by planned enrollment of the 41 interventional ones that give a count, is one of 2 that started in 2019, is one of 19 with no phase, and was the 31st registered.
1,028 studies on the registry are indexed under Tobacco Use Disorder; 128 are open to participants now.
Browse Tobacco Use Disorder studies →10 of the 43 studies in Tobacco Use Disorder with a site in Canada are open now. Recruiting first, the newest first:
St. Justine's Hospital · Sites in Canada
Ages 18+
Waypoint Centre for Mental Health Care · Sites in Canada
Ages 18+
Ottawa Heart Institute Research Corporation · Sites in Canada
Ages 18+
Centre for Addiction and Mental Health · Sites in Canada
Ages 18–85
Centre for Addiction and Mental Health · Sites in Canada
Ages 18–70
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 95 Tobacco Use Disorder studies recruiting now, 42 (44%) set no upper age limit and 50 (53%) stop at 75 or younger; 6 take children under 18; 37 take healthy volunteers.
This study: 16 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 10 · Phase 3 3 · Phase 4 9
First in 2005; this study’s year is marked. 2 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 250 is above the median of 90 across 893 interventional studies indexed under Tobacco Use Disorder.
Median enrollment 43 across the 41 interventional studies, 180 across the 2 observational. Of the 28 that completed or were terminated, 7 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 43 has an industry lead sponsor. The 10 most frequent:
Ottawa Hospital Research Institute is the lead sponsor of 547 studies on the registry; 99 are open to participants now.
Ottawa Hospital Research Institute has 3 studies filed under Tobacco Use Disorder — fewer than ten, so there is no comparison to draw.
5 of the studies in Tobacco Use Disorder with a site in Canada that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07059377Phase 3Ottawa Heart Institute Research CorporationSemaglutide for Smoking Cessation in Patients With Diabetes | 2026-12 |
| NCT03249428Ottawa Hospital Research InstituteCytisine vs Nicotine Replacement Therapy | 2027-03 |
| NCT03506867Ottawa Hospital Research InstituteHealthy People Initiative (HPI) | 2027-03-31 |
| NCT06346028Centre for Addiction and Mental HealthImplementation of Transcranial Magnetic Stimulation for Smoking Cessation | 2027-06-30 |
| NCT04163081Ottawa Heart Institute Research CorporationThe INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments | 2027-09 |
Add all 5 to your calendar (.ics) → With an account.
Among the 43 studies in Tobacco Use Disorder with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Addictions do not occur in isolation. Tackling addictions requires addressing social determinants such as isolation, homelessness, marginalization, and unemployment. Research on individuals living with or at risk for HIV/AIDS highlights that unemployment correlates with higher levels of depression, anxiety, and social isolation compared to employment. In Ottawa, the PROMPT project engaged homeless or at-risk populations, including people who use drugs and those living with or at risk for HIV/AIDS or Hepatitis C using the Bridge ModelTM, a pragmatic community-based participatory action research approach operationalized through earlier projects at the Bridge Engagement Center in Ottawa, Canada. The PROMPT project demonstrated that implementing multi-component, complex interventions is both feasible and effective, achieving broader socio-economic outcomes beyond reduction and quitting tobacco and poly-substance use. However, PROMPT participants identified a lack of social and recovery capital -family and social connections, opportunities for volunteering and jobs- as a major barrier to recovery. To address this, we conducted a six-month feasibility pilot study with 20 PROMPT participants. By its conclusion, 15 participants were engaged in small paid or volunteer roles, including educational opportunities, fostering both social integration and recovery. Insights from this pilot study informed the design of a larger community-based multi-site pragmatic randomized trial (RCT) to further evaluate the effectiveness of the Bridge ModelTM, the Healthy People Initiative (HPI) project. The Healthy People Initiative (HPI) is a community-based, participatory, pragmatic parallel-arm multi-site with a cross-over design, recruiting 250 participants (16+) at risk of homelessness or low socioeconomic status in Ottawa and Toronto, Canada.
Title of Trial: A Healthy People Initiative (HPI) - Community-Based Participatory Action Pragmatic Parallel Arm Multi-Site Randomized Controlled Trial using The Bridge ModelTM in Systemically Disadvantaged Populations: HPI Trial Protocol
Short Title of Trial: HPI Trial
Principal Investigator: Smita Pakhalé
Trial Sites: Ottawa (The Bridge Engagement Centre) \& Toronto (Parkdale Activity Recreation Centre)
Primary outcome: The Healthy People Initiative (HPI) randomized controlled trial (RCT) builds on the pilot study to evaluate changes in participants' self-reported quality of life (QoL) as the primary outcome while implementing the Bridge Model™ approach to address tobacco management.
Secondary outcomes: The secondary objective is to quantify reductions in tobacco use and quitting tobacco use altogether, with quit rates validated biochemically, and changes in self-efficacy.
Tertiary outcomes: These include evaluating process-related metrics such as participant enrolment rates, consent rates, and adherence to protocol; estimating implementation costs to guide future cost-effectiveness analyses; and assessing additional patient-reported outcomes such as self-efficacy, participation in education or employment, and reductions in polysubstance use. Additionally, a cost-utility analysis from a health system perspective will assess the economic impact of the 52-week intervention by measuring total costs and healthcare utilization, linking trial data to administrative health records. We aim to provide robust evidence to support the utility of the Bridge ModelTM in addressing health and social inequities through community-driven, peer-led interventions that integrate social determinants with individual health outcomes.
Primary Objective: To assess the feasibility of a randomized controlled trial investigating access to improvements in 'social capital' in the low income population in Ottawa and Toronto.
Study Design \& Population: The HPI study is a crossover, community-based, multi-site pragmatic RCT (1:1 allocation ratio) in Ottawa and Toronto. It uses a 12-month follow-up to evaluate short- and long-term effects of the intervention on health, social, and economic outcomes. Data sources include self-reports, biochemical validation, and administrative health records
Sample Size: 250
Trial Arms: The HPI RCT has two arms: usual care and intervention (Figure 1). The intervention arm employs the Bridge ModelTM, offering life-skills workshops, social integration, peer guidance, system navigation (e.g., housing), and APN (Advanced Practice Nurse) or NP (Nurse Practitioner) counselling, including primary care, preventive services, and referrals. Both arms receive monthly follow-ups from peers and APN/NP. Usual care includes resource information and counselling, with an option to switch to the intervention arm after six months. All participants receive nicotine replacement therapy (NRT) for 12 months as needed.
Trial Duration: 12 months Follow-up Duration: 12 months
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
We will provide the participants in this arm with pamphlets and knowledge about available services in the city through partner agencies.
Behavioral: Life skills, training, education and work/volunteer opportunities
The life skills, training, education, work/volunteer opportunities, and peer support arm will be offered to the usual care arm participants after the first six months of study enrollment.
Behavioral: Usual Care
Intervention arm will receive proactive and sustained access to enhanced education and socio-economic supports (e.g. volunteer and/or work opportunities).
We will provide the participants in this arm with pamphlets and knowledge about available services in the city through partner agencies.
Self-Reported Quality of Life
To assess the trend in self-reported quality of life using the European Quality of Life 5 Dimensions 5 Level Version.
Time frame: 12 Months
Self-Reported Efficacy
To estimate change in self-reported self-efficacy.
Time frame: 12 months
Tobacco use
To estimate self-reported reduced or quit tobacco use rate (corroborated with the measurement of exhaled Carbon Monoxide) and poly-substance use rate.
Time frame: 12 months
Consent and Protocol Violation Rate
The consent rate of eligible participants and the rate of protocol violations resulting in cross contamination of the groups receiving study intervention
Time frame: 12 months
Healthcare Utilization Rate
To compare healthcare utilization (ER visits and hospitalizations) over one year before and after the study by linking the trial data to health administrative data available at the Institute for Clinical and Evaluative Sciences (ICES).
Time frame: 12 months
Access to Work, Training, and Volunteer Opportunities
To assess access to work, training, or volunteering positions using a self-reported online survey.
Time frame: 12 months
Costs of Poverty Reduction Intervention
To estimate the costs of poverty reduction intervention (life skills workshops, training, and education/volunteer/employment opportunities.
Time frame: 12 months
Average Recruitment Rate
To assess the ability of participating sites to enroll an average of 6 participants per month.
Time frame: 12 months
Poly-substance use rates
Reductions in polysubstance use (biochemically validated)
Time frame: 12 months
Plan to share: Yes — Upon request study de-identified data will be made available to interested and qualified researchers.
Time frame: Upon request study de-identified data will be made available to interested and qualified researchers. No time frame necessary.
Access criteria: No access criteria. De-identified raw data will be available upon request.
No publications or documents are linked to this record.
Started Jan 2019 (actual). Primary completion is estimated for Mar 2027, 98 months after the start.
Of 257 non-industry interventional studies with no phase under Tobacco Use Disorder, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 51. This study's planned 98 months is above that.
Counting every sponsor, half of 267 studies reached it within 32 months; a quarter within 16 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ottawa Hospital Research Institute →